Therapeutic Endoscopic Ultrasound (EUS) Registry
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Gastrointestinal Disease
- Sponsor
- Methodist Health System
- Enrollment
- 400
- Locations
- 1
- Primary Endpoint
- clinical success rates
- Status
- Enrolling By Invitation
- Last Updated
- last year
Overview
Brief Summary
The purpose of this prospective registry is to assess long-term data on efficacy, safety and clinical outcome of Therapeutic Endoscopic ultrasound (T-EUS) . The registry will evaluate technical feasibility, clinical outcome, safety profile and overall clinical management through medical chart review. The procedures we are evaluating are all clinically indicated and will not be prescribed to someone to participate in this research study.
Detailed Description
This study is a prospective, observational, medical chart review. There will be a retrospective chart review for patients who underwent endoscopic suturing procedures from October 2014 - May 2019. Those subjects will undergo no additional tests and procedures as part of this study. In order to validate these procedures and broaden its use beyond tertiary centers, it is crucial to understand its efficacy and success rate. The objective of the study is to evaluate retrospectively and prospectively the efficacy and safety of T-EUS procedures.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Any patient who has undergone clinically indicated and/or standard of care T-EUS procedures from October 2014 - May 2019
- •Any patient who will undergo clinically indicated and/or standard of care T-EUS procedures from June 2019 - June 2027
Exclusion Criteria
- •Any patient who has not undergone endoscopic ultrasound would be excluded from the study.
- •Below 18 years of age
Outcomes
Primary Outcomes
clinical success rates
Time Frame: October 2014 - June 2022
Documentation of clinical success rates
Documentation of Safety
Time Frame: October 2014 - June 2022
Number of subjects with Adverse Events; Type, frequency and intensity of adverse events